propranolol has been researched along with Lung Diseases, Obstructive in 26 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Lung Diseases, Obstructive: Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "5." | 6.64 | Clinical evaluation of atenolol in hypertension. ( Aberg, H; Hansson, L; Henningsen, NC; Jameson, S; Karlberg, BE; Westerlund, A, 1976) |
| "The effects on ventilation of the non-selective beta-blocker propranolol, and the relatively cardioselective beta-blocker, metoprolol, were compared in a randomized single-blind crossover study in 16 patients with asthma, bronchitis and emphysema (American Thoracic Society criteria)." | 5.05 | Influence of cardioselectivity and respiratory disease on pulmonary responsiveness to beta-blockade. ( Ahmad, D; Carruthers, SG; Clague, HW, 1984) |
| "Disabling propranolol-induced bronchospasm occasionally prevents use of this drug in patients with chronic obstructive pulmonary disease (COPD)." | 3.66 | Inhalation challenge with carbachol and isoproterenol to predict bronchospastic response to propranolol in COPD. ( Hyde, RW; Jackson, DH; Popio, KA; Swinburne, AJ; Utell, MJ, 1983) |
| "Propranolol was associated with a documented increase in the degree of bronchial obstruction." | 2.66 | [Effect of different beta-receptor blockers on the respiratory function of patients with chronic obstructive pulmonary disease and arterial hypertension]. ( Dorow, P, 1987) |
| "Propranolol was the only drug that significantly increased airways obstruction (FEV1, specific airways resistance)." | 2.65 | Labetalol, beta blockers, and acute deterioration of chronic airway obstruction. ( Adam, WR; Barter, CE; Meagher, EJ, 1982) |
| "5." | 2.64 | Clinical evaluation of atenolol in hypertension. ( Aberg, H; Hansson, L; Henningsen, NC; Jameson, S; Karlberg, BE; Westerlund, A, 1976) |
| " However, a dose-response curve to methacholine is helpful." | 1.28 | Characteristics of bronchial hyperresponsiveness in chronic obstructive pulmonary disease and in asthma. ( Anderson, SD; Du Toit, JI; Peat, JK; Salome, CM; Smith, CM; Woolcock, AJ; Zhang, YG, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 22 (84.62) | 18.7374 |
| 1990's | 4 (15.38) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jenne, JW | 1 |
| Wunderlich, J | 1 |
| Macha, HN | 1 |
| Wudicke, H | 1 |
| Huckauf, H | 1 |
| Trauth, HA | 1 |
| Adam, WR | 1 |
| Meagher, EJ | 1 |
| Barter, CE | 1 |
| Whitsett, TL | 1 |
| Levin, DC | 1 |
| Manion, CV | 1 |
| Clague, HW | 1 |
| Ahmad, D | 1 |
| Carruthers, SG | 1 |
| de Vries, K | 1 |
| Koëter, GH | 2 |
| Gökemeyer, JD | 1 |
| Popio, KA | 1 |
| Jackson, DH | 1 |
| Utell, MJ | 1 |
| Swinburne, AJ | 1 |
| Hyde, RW | 1 |
| Vedal, S | 1 |
| Anantharaman, A | 1 |
| Israel, RH | 1 |
| Chester, EH | 1 |
| Schwartz, HJ | 1 |
| Fleming, GM | 1 |
| Wells, PH | 1 |
| Kaplan, JA | 1 |
| Cronenwett, JL | 1 |
| Beil, M | 1 |
| Ulmer, WT | 2 |
| Tivenius, L | 1 |
| Lanser, K | 1 |
| Hansson, L | 1 |
| Karlberg, BE | 1 |
| Aberg, H | 1 |
| Westerlund, A | 1 |
| Henningsen, NC | 1 |
| Jameson, S | 1 |
| Nordstrom, LA | 1 |
| MacDonald, F | 1 |
| Gobel, FL | 1 |
| Scott, JS | 2 |
| Berney, CE | 1 |
| Derksen, FJ | 2 |
| Robinson, NE | 2 |
| Fogari, R | 1 |
| Zoppi, A | 1 |
| Tettamanti, F | 1 |
| Poletti, L | 1 |
| Rizzardi, G | 1 |
| Fiocchi, G | 1 |
| Woolcock, AJ | 1 |
| Anderson, SD | 1 |
| Peat, JK | 1 |
| Du Toit, JI | 1 |
| Zhang, YG | 1 |
| Smith, CM | 1 |
| Salome, CM | 1 |
| Broadstone, RV | 1 |
| Giorgis, GE | 1 |
| Galietti, F | 1 |
| Miravalle, C | 1 |
| Barberis, S | 1 |
| Massaglia, GM | 1 |
| Onoscuri, E | 1 |
| Dorow, P | 1 |
| Hirschler-Schulte, CJ | 1 |
| Hylkema, BS | 1 |
| Kones, RJ | 1 |
| Phillips, JH | 1 |
| Hersh, J | 1 |
| Warner, H | 1 |
3 reviews available for propranolol and Lung Diseases, Obstructive
| Article | Year |
|---|---|
Optimal management of patients with ischemic heart disease for noncardiac surgery by complementary anesthesiologist and cardiologist interaction.
Topics: Aged; Anesthesia; Anesthesiology; Arrhythmias, Cardiac; Cardiology; Cerebrovascular Disorders; Coron | 1981 |
Variables that affect the expansion rate and rupture of abdominal aortic aneurysms.
Topics: Adrenergic beta-Antagonists; Aortic Aneurysm, Abdominal; Aortic Rupture; Comorbidity; Diastole; Dise | 1996 |
Therapy of common arrhythmias.
Topics: Action Potentials; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bradycardia; Digitalis Glycosides; | 1974 |
10 trials available for propranolol and Lung Diseases, Obstructive
| Article | Year |
|---|---|
Beta-adrenoceptor blockers and terbutaline in patients with chronic obstructive lung disease. Effects and interaction after oral administration.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Clinical Trials as Topic; Double-Blind Meth | 1980 |
Labetalol, beta blockers, and acute deterioration of chronic airway obstruction.
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Ethanolamines; Humans; Hypertension; Labetalol; Lung Di | 1982 |
Influence of cardioselectivity and respiratory disease on pulmonary responsiveness to beta-blockade.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Asthma; Bronchitis; Female; Heart; Humans; Isoproterenol; | 1984 |
Adverse effect of propranolol on airway function in nonasthmatic chronic obstructive lung disease.
Topics: Administration, Oral; Airway Resistance; Clinical Trials as Topic; Double-Blind Method; Heart Rate; | 1981 |
[Effects of a new cardioselective beta-adrenergic blocker (atenolol) on airway resistance in chronic obstructive disease (author's transl)].
Topics: Adult; Aged; Airway Resistance; Atenolol; Blood Pressure; Bronchi; Chronic Disease; Clinical Trials | 1977 |
Effects of muliple doses of metoprolol and propranolol on ventilatory function in patients with chronic obstructive lung disease.
Topics: Adult; Aged; Blood Pressure; Chronic Disease; Clinical Trials as Topic; Dose-Response Relationship, | 1976 |
[Propranolol and pindolol in chronic obstructive lung disease (author's transl)].
Topics: Airway Resistance; Blood Pressure; Chronic Disease; Clinical Trials as Topic; Fenoterol; Humans; Lun | 1976 |
Clinical evaluation of atenolol in hypertension.
Topics: Antihypertensive Agents; Atenolol; Clinical Trials as Topic; Humans; Hypertension; Lung Diseases, Ob | 1976 |
Comparative effects of celiprolol, propranolol, oxprenolol, and atenolol on respiratory function in hypertensive patients with chronic obstructive lung disease.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Celiprolol; Forced Expiratory Volume | 1990 |
[Effect of different beta-receptor blockers on the respiratory function of patients with chronic obstructive pulmonary disease and arterial hypertension].
Topics: Adrenergic beta-Antagonists; Adult; Betaxolol; Blood Pressure; Female; Heart Rate; Humans; Hypertens | 1987 |
13 other studies available for propranolol and Lung Diseases, Obstructive
| Article | Year |
|---|---|
Beta blockers and COPD.
Topics: Adrenergic beta-Antagonists; Airway Resistance; Animals; Humans; Lung Diseases, Obstructive; Metopro | 1980 |
[Antihypertensive treatment with beta receptor blockers and obstructive ventilatory disorder (author's transl)].
Topics: Adrenergic beta-Antagonists; Adult; Bronchitis; Dose-Response Relationship, Drug; Female; Humans; Hy | 1981 |
Comparison of the beta 1 and beta 2 adrenoceptor blocking properties of acebutolol and propranolol.
Topics: Acebutolol; Adrenergic beta-Antagonists; Blood Pressure; Double-Blind Method; Forced Expiratory Flow | 1982 |
Some aspects of the regulation of the bronchial tree in obstructive lung disease: an introduction.
Topics: Acetylcholine; Bronchi; Bronchial Provocation Tests; Histamine; Humans; Lung Diseases, Obstructive; | 1982 |
Inhalation challenge with carbachol and isoproterenol to predict bronchospastic response to propranolol in COPD.
Topics: Bronchial Spasm; Carbachol; Female; Humans; Isoproterenol; Lung; Lung Diseases, Obstructive; Male; M | 1983 |
Hidden asthmatic. Identification required for propranolol usage.
Topics: Angina Pectoris; Asthma; Diagnosis, Differential; Humans; Lung Diseases, Obstructive; Male; Middle A | 1980 |
Effect of propranolol on respiratory function and exercise tolerance in patients with chronic obstructive lung disease.
Topics: Airway Resistance; Blood Pressure; Bronchitis; Chronic Disease; Exercise Test; Heart Rate; Humans; I | 1975 |
Beta-adrenergic receptor activity in ponies with recurrent obstructive pulmonary disease.
Topics: Aerosols; Animals; Atenolol; Butoxamine; Histamine; Horse Diseases; Horses; Isoproterenol; Lung Dise | 1991 |
Characteristics of bronchial hyperresponsiveness in chronic obstructive pulmonary disease and in asthma.
Topics: Asthma; Bronchi; Bronchial Provocation Tests; Dose-Response Relationship, Drug; Female; Forced Expir | 1991 |
Beta-adrenergic blockade in ponies with recurrent obstructive pulmonary disease.
Topics: Airway Resistance; Animals; Horse Diseases; Horses; Lung; Lung Compliance; Lung Diseases, Obstructiv | 1988 |
[Possibilities of using cardioselective beta blocking agents in patients with chronic obstructive bronchopneumopathies].
Topics: Acebutolol; Adrenergic beta-Antagonists; Aerosols; Aged; Atenolol; Blood Pressure; Female; Forced Ex | 1986 |
[No beta blockers without a COPD anamnesis].
Topics: Acute Disease; Airway Obstruction; Female; Humans; Lung Diseases, Obstructive; Medical History Takin | 1985 |
Mechanism and management of chaotic atrial mechanism.
Topics: Acute Disease; Chronic Disease; Coronary Disease; Digitalis Glycosides; Drug Therapy, Combination; E | 1974 |